LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF TOCILIZUMAB IN RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS

被引：1
|
作者：
Farah, Z. [1 ]
Reddy, V. [2 ]
Ali, S. [1 ]
Price-Kuehne, F. [1 ]
Moore, S. [2 ]
Mackworth-Young, C. [1 ]
Ehrenstein, M. [2 ]
机构：
[1] Charing Cross Hosp, Rheumatol, London, England
[2] Univ Coll London Hosp, Rheumatol, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4452
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0183
引用
收藏
页码：734 / 735
页数：2
相关论文
共 50 条
  • [41] LONG-TERM SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: LONG-TERM FOLLOW-UP OF CLINICAL TRIALS AND RETREATMENT POPULATION
    van Vollenhoven, Ronald F.
    Emery, Paul
    Bingham, Clifton O.
    Keystone, Edward C.
    Fleischmann, Roy M.
    Furst, Daniel E.
    Macey, Katherine
    Sweetster, Marianne T.
    Lehane, Patricia B.
    Farmer, Pamela
    Long, Simon G.
    RHEUMATOLOGY, 2010, 49 : I104 - I104
  • [42] LONG-TERM EFFICACY OF TOCILIZUMAB UP TO 3.5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM ANALYSIS OF LONG-TERM EXTENSION STUDIES
    Calvo, A.
    Sid, D.
    Saavedra, M.
    Kissel, K.
    Alecock, E.
    Smolen, J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S34 - S34
  • [43] Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
    V. Shaygannejad
    E. Fayyazi
    S. Badihian
    O. Mirmosayyeb
    N. Manouchehri
    F. Ashtari
    N. Asgari
    Journal of Neurology, 2019, 266 : 642 - 650
  • [44] Long-term safety and efficacy of tocilizumab (an anti-IL-6 receptor monoclonal antibody) in monotherapy, in patients with rheumatoid arthritis
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    Kishimoto, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 122 - 122
  • [45] Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
    Shaygannejad, V.
    Fayyazi, E.
    Badihian, S.
    Mirmosayyeb, O.
    Manouchehri, N.
    Ashtari, F.
    Asgari, N.
    JOURNAL OF NEUROLOGY, 2019, 266 (03) : 642 - 650
  • [46] THE SAFETY AND EFFICACY OF THE USE OF METHOTREXATE IN LONG-TERM THERAPY FOR RHEUMATOID-ARTHRITIS
    KREMER, JM
    LEE, JK
    ARTHRITIS AND RHEUMATISM, 1986, 29 (07): : 822 - 831
  • [47] The long-term remission of rheumatoid arthritis with a single cycle of rituximab
    Glisic, Branislava
    Knezevic, Bojana
    VOJNOSANITETSKI PREGLED, 2012, 69 (01) : 78 - 80
  • [48] Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis
    Burmester, Gerd R.
    Strand, Vibeke
    Kivitz, Alan J.
    Hu, Chih-Chi
    Wang, Sheldon
    van Hoogstraten, Hubert
    Klier, Gabriella L.
    Fleischmann, Roy
    RHEUMATOLOGY, 2023, 62 (10) : 3268 - 3279
  • [49] 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
    S Yokota
    T Imagawa
    T Miyamae
    K Kasai
    M Mori
    N Nishimoto
    T Kishimoto
    Pediatric Rheumatology, 6 (Suppl 1)
  • [50] Long-term safety and efficacy of tocilizumab in patients with systemic juvenile idiopathic arthritis (JIA) under the extension and long-term trials
    Yokota, Shumpei
    Imagawa, Tomoyuki
    Miyamae, Takako
    Mori, Masaaki
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S631 - S632
12345